MiMedx Group Inc - ESG Rating & Company Profile powered by AI
This analysis of MiMedx Group Inc was prepared by All Street Sevva using cutting edge machine learning. Other corporations in the rating industry group for MiMedx Group Inc are shown below. The Disclosure rating includes seventeen UN Sustainable Development Goals including: 'No Poverty', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'.
MiMedx Group Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 4.0, social score of 3.4 and governance score of 7.0.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 999 | Xeris Pharmaceuticals Inc | 5.1 | High |
| 999 | Vascular Biogenics Ltd | 5.1 | High |
| 1047 | MiMedx Group Inc | 5.0 | High |
| 1047 | Anixa Biosciences Inc | 5.0 | High |
| 1047 | Amarin Corporation PLC | 5.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does MiMedx Group Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes MiMedx Group Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes MiMedx Group Inc report the average age of the workforce?
Sign up for free to unlockDoes MiMedx Group Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes MiMedx Group Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes MiMedx Group Inc disclose cybersecurity risks?
Sign up for free to unlockDoes MiMedx Group Inc offer flexible work?
Sign up for free to unlockDoes MiMedx Group Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes MiMedx Group Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes MiMedx Group Inc conduct supply chain audits?
Sign up for free to unlockDoes MiMedx Group Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes MiMedx Group Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes MiMedx Group Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes MiMedx Group Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes MiMedx Group Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes MiMedx Group Inc disclose water use targets?
Sign up for free to unlockDoes MiMedx Group Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid MiMedx Group Inc have a product recall in the last two years?
Sign up for free to unlockDoes MiMedx Group Inc disclose incidents of discrimination?
Sign up for free to unlockDoes MiMedx Group Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas MiMedx Group Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes MiMedx Group Inc disclose parental leave metrics?
Sign up for free to unlockDoes MiMedx Group Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes MiMedx Group Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes MiMedx Group Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes MiMedx Group Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes MiMedx Group Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes MiMedx Group Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs MiMedx Group Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes MiMedx Group Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes MiMedx Group Inc disclose its waste policy?
Sign up for free to unlockDoes MiMedx Group Inc report according to TCFD requirements?
Sign up for free to unlockDoes MiMedx Group Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes MiMedx Group Inc disclose energy use targets?
Sign up for free to unlockDoes MiMedx Group Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes MiMedx Group Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for MiMedx Group Inc
These potential risks are based on the size, segment and geographies of the company.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.